Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sindy Vrecko
Observed names:
S Vrecko,
S. Vrecko
Observed institutions:
Inserm,
Université Bourgogne Franche-Comté,
Interactions Hôte-Greffon-Tumeur & Ingénierie Cellulaire et Génique,
Université de Franche-Comté
OpenAlex ID:
A5080310478
Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
2016
·
Laurent Beziaud
, Laura Mansi
, et al.
·
Cancer Research
·
60
Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment
2018
·
Sindy Vrecko
, David Guenat
, et al.
·
Oncotarget
·
7
PDF
High prevalence of abnormal cervical smears in a hospital cohort of French women beyond the upper age limit screening program
2015
·
Alexandra Luquain
, Essaada Belglaiaa
, et al.
·
Preventive Medicine
·
3
Data from Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
2023
·
Laurent Beziaud
, Laura Mansi
, et al.
Supplementary Figure S2 from Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
2023
·
Laurent Beziaud
, Laura Mansi
, et al.
Supplementary Figure S1 from Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
2023
·
Laurent Beziaud
, Laura Mansi
, et al.
Supplementary Table S1 from Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
2023
·
Laurent Beziaud
, Laura Mansi
, et al.
PDF
Supplementary methods from Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
2023
·
Laurent Beziaud
, Laura Mansi
, et al.
Supplementary Figure S6 from Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
2023
·
Laurent Beziaud
, Laura Mansi
, et al.
Supplementary Figure S4 from Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
2023
·
Laurent Beziaud
, Laura Mansi
, et al.
Supplementary Figure S3 from Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
2023
·
Laurent Beziaud
, Laura Mansi
, et al.
Supplementary Figure S5 from Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
2023
·
Laurent Beziaud
, Laura Mansi
, et al.
Supplementary figure legends from Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
2023
·
Laurent Beziaud
, Laura Mansi
, et al.
Supplementary Figure S5 from Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
2023
·
Laurent Beziaud
, Laura Mansi
, et al.
Supplementary Table S1 from Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
2023
·
Laurent Beziaud
, Laura Mansi
, et al.
Supplementary Figure S6 from Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
2023
·
Laurent Beziaud
, Laura Mansi
, et al.
Supplementary Figure S3 from Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
2023
·
Laurent Beziaud
, Laura Mansi
, et al.
Supplementary Figure S1 from Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
2023
·
Laurent Beziaud
, Laura Mansi
, et al.
Etude des réponses lymphocitaires T spécifiques de néoantigènes tumoraux après immunomodulations induites par des chimiothérapies
2018
·
Sindy Vrecko
·
theses.fr (ABES)
PDF
Étude des mécanismes impliqués dans la modulation des réponses immunitaires T antitumorales induites par la radio-chimiothérapie concomitante (RTCTc)
2017
·
E. Lauret Marie Joseph
, C. Bonin
, et al.
·
Revue des Maladies Respiratoires
Modulation de la réponse immunitaire anti-tumorale induite par docétaxel, cisplatine et 5-fluorouracile (DCF) dans un modèle de cancer du canal anal
2014
·
S Vrecko
, P Letondal
, et al.
·
Revue Francophone des Laboratoires
Show more works
View as search
Works count:
21
Citation count:
70
H-index:
3
I10-index:
1
Year
Topic
Type